Modulation de l'échangeur Na+/H+ de type 1 (NHE1) par le canal sodique dépendant du voltage Nav1.5 (implication dans l'invasivité de cellules cancéreuses mammaires humaines)

Les cellules cancéreuses mammaires invasives expriment des canaux sodiques NaV1.5 dont l activité semble être associée au développement métastatique. L activité de ce canal dans les cellules MDA-MB-231 conduit à une acidification péricellulaire favorable à l activité des cathepsines à cystéine B et S extracellulaires et à la dégradation de la matrice extracellulaire. Au cours de cette thèse, nous avons montré que l échangeur NHE1 est le principal régulateur du pH des cellules MDA-MB-231 et que l activité du canal NaV1.5 augmente l activité d efflux de protons par NHE1 vraisemblablement par modulation allostérique. NaV1.5 et NHE1 sont co-localisés dans des radeaux lipidiques et plus particulièrement dans les invadopodes des cellules MDA-MB-231. Les activités de NHE1 et NaV1.5 stimulent l activité protéolytique des invadopodes. Enfin, l activité du canal NaV1.5 semble moduler le cytosquelette et la morphologie des cellules cancéreuses MDA-MB-231 pour leur donner un phénotype invasif. En conclusion, NaV1.5 augmente l activité de NHE1 dans les invadopodes stimulant ainsi l invasivité des cellules cancéreuses mammaires.Invasive breast cancer cells express NaV1.5 sodium channels which activity seems to be associated with metastatic progression. The activity of the channel in MDA-MB-231 cells leads to a pericellular acidification favourable for the activity of extracellular cysteine cathepsins B and S and for extracellular matrix degradation. During this thesis, we have shown that NHE1 exchanger is the main pH regulator in MDA-MB-231 cells and that the activity of NaV1.5 channels increases protons efflux activity of NHE1 possibly through allosteric modulation. NaV1.5 and NHE1 are co-localised in lipid rafts and in invadopodia of MDA-MB-231 cells. The activity of NHE1 and NaV1.5 promotes the proteolytic activity of invadopodia. Finally, the activity of NaV1.5 channels seems to modulate cytoskeleton and morphology of MDA-MB-231 cancer cells to promote the acquisition of a proinvasive phenotype. In conclusion NaV1.5 increases NHE1 activity in invadopodia to stimulate breast cancer cells invasiveness.TOURS-Bibl.électronique (372610011) / SudocSudocFranceF

Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Cancer Metabolism

Tumors are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment, resistance, and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging, and stratification for personalized treatments. These topics were addressed at the 4th annual meeting of the International Society of Cancer Metabolism (ISCaM) in Bertinoro, Italy, on 19-21 October 2017

P2X7 Receptor Promotes Mouse Mammary Cancer Cell Invasiveness and Tumour Progression, and Is a Target for Anticancer Treatment

The P2X7 receptor is an ATP-gated cation channel with a still ambiguous role in cancer progression, proposed to be either pro- or anti-cancerous, depending on the cancer or cell type in the tumour. Its role in mammary cancer progression is not yet defined. Here, we show that P2X7 receptor is functional in highly aggressive mammary cancer cells, and induces a change in cell morphology with fast F-actin reorganization and formation of filopodia, and promotes cancer cell invasiveness through both 2- and 3-dimensional extracellular matrices in vitro. Furthermore, P2X7 receptor sustains Cdc42 activity and the acquisition of a mesenchymal phenotype. In an immunocompetent mouse mammary cancer model, we reveal that the expression of P2X7 receptor in cancer cells, but not in the host mice, promotes tumour growth and metastasis development, which were reduced by treatment with specific P2X7 antagonists. Our results demonstrate that P2X7 receptor drives mammary tumour progression and represents a pertinent target for mammary cancer treatment

Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Cancer Metabolism

Tumors are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment, resistance, and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging, and stratification for personalized treatments. These topics were addressed at the 4th annual meeting of the International Society of Cancer Metabolism (ISCaM) in Bertinoro, Italy, on 19–21 October 2017

Modulation de l'échangeur Na + /H + de type 1 (NHE1) par le canal sodique dépendant du voltage Na V 1.5 Implication dans l'invasivité de cellules cancéreuses mammaires humaines

Invasive breast cancer cells express NaV1.5 sodium channels which activity seems to be associated with metastatic progression. The activity of the channel in MDA-MB-231 cells leads to a pericellular acidification favourable for the activity of extracellular cysteine cathepsins B and S and for extracellular matrix degradation. During this thesis, we have shown that NHE1 exchanger is the main pH regulator in MDA-MB-231 cells and that the activity of NaV1.5 channels increases protons efflux activity of NHE1 possibly through allosteric modulation. NaV1.5 and NHE1 are co-localised in lipid rafts and in invadopodia of MDA-MB-231 cells. The activity of NHE1 and NaV1.5 promotes the proteolytic activity of invadopodia. Finally, the activity of NaV1.5 channels seems to modulate cytoskeleton and morphology of MDA-MB-231 cancer cells to promote the acquisition of a proinvasive phenotype. In conclusion NaV1.5 increases NHE1 activity in invadopodia to stimulate breast cancer cells invasiveness.Les cellules cancéreuses mammaires invasives expriment des canaux sodiques NaV1.5 dont l’activité semble être associée au développement métastatique. L’activité de ce canal dans les cellules MDA-MB-231 conduit à une acidification péricellulaire favorable à l’activité des cathepsines à cystéine B et S extracellulaires et à la dégradation de la matrice extracellulaire. Au cours de cette thèse, nous avons montré que l’échangeur NHE1 est le principal régulateur du pH des cellules MDA-MB-231 et que l’activité du canal NaV1.5 augmente l’activité d’efflux de protons par NHE1 vraisemblablement par modulation allostérique. NaV1.5 et NHE1 sont co-localisés dans des radeaux lipidiques et plus particulièrement dans les invadopodes des cellules MDA-MB-231. Les activités de NHE1 et NaV1.5 stimulent l’activité protéolytique des invadopodes. Enfin, l’activité du canal NaV1.5 semble moduler le cytosquelette et la morphologie des cellules cancéreuses MDA-MB-231 pour leur donner un phénotype invasif. En conclusion, NaV1.5 augmente l’activité de NHE1 dans les invadopodes stimulant ainsi l’invasivité des cellules cancéreuses mammaires

Modulation of type 1 Na+/H+ exchanger (NHE1) by Nav1.5 voltage-gated sodium channel : involvement in human breast cancer cells invasiveness

Les cellules cancéreuses mammaires invasives expriment des canaux sodiques NaV1.5 dont l’activité semble être associée au développement métastatique. L’activité de ce canal dans les cellules MDA-MB-231 conduit à une acidification péricellulaire favorable à l’activité des cathepsines à cystéine B et S extracellulaires et à la dégradation de la matrice extracellulaire. Au cours de cette thèse, nous avons montré que l’échangeur NHE1 est le principal régulateur du pH des cellules MDA-MB-231 et que l’activité du canal NaV1.5 augmente l’activité d’efflux de protons par NHE1 vraisemblablement par modulation allostérique. NaV1.5 et NHE1 sont co-localisés dans des radeaux lipidiques et plus particulièrement dans les invadopodes des cellules MDA-MB-231. Les activités de NHE1 et NaV1.5 stimulent l’activité protéolytique des invadopodes. Enfin, l’activité du canal NaV1.5 semble moduler le cytosquelette et la morphologie des cellules cancéreuses MDA-MB-231 pour leur donner un phénotype invasif. En conclusion, NaV1.5 augmente l’activité de NHE1 dans les invadopodes stimulant ainsi l’invasivité des cellules cancéreuses mammaires.Invasive breast cancer cells express NaV1.5 sodium channels which activity seems to be associated with metastatic progression. The activity of the channel in MDA-MB-231 cells leads to a pericellular acidification favourable for the activity of extracellular cysteine cathepsins B and S and for extracellular matrix degradation. During this thesis, we have shown that NHE1 exchanger is the main pH regulator in MDA-MB-231 cells and that the activity of NaV1.5 channels increases protons efflux activity of NHE1 possibly through allosteric modulation. NaV1.5 and NHE1 are co-localised in lipid rafts and in invadopodia of MDA-MB-231 cells. The activity of NHE1 and NaV1.5 promotes the proteolytic activity of invadopodia. Finally, the activity of NaV1.5 channels seems to modulate cytoskeleton and morphology of MDA-MB-231 cancer cells to promote the acquisition of a proinvasive phenotype. In conclusion NaV1.5 increases NHE1 activity in invadopodia to stimulate breast cancer cells invasiveness

Interaction between adipose tissue and cancer cells: role for cancer progression

International audienc

pH regulators in invadosomal functioning: Proton delivery for matrix tasting

International audienc

Common responses of tumors and wounds to hypoxia.

Hypoxia is a characteristic of tumors and wounds. Hypoxic cells develop 2 common strategies to face hypoxia: the glycolytic switch and the angiogenic switch. At the onset of hypoxia, alleviation of the Pasteur effect ensures short-term cell survival. Long-term hypoxic cell survival requires a further acceleration of the glycolytic flux under the control of hypoxia-inducible factor 1 that stimulates the expression of most glycolytic transporters and enzymes, uncouples glycolysis from the TCA cycle, and rewires glycolysis to lactic fermentation. Hypoxic cells also trigger angiogenesis, a process that aims to restore normal microenvironmental conditions. Transcription factors (hypoxia-inducible factor 1, nuclear factor κB, activator protein 1) and lactate cooperate to stimulate the expression of proangiogenic agents. Cancer cells differ from normal hypoxic cells by their proliferative agenda and by a high metabolic heterogeneity. These effects in tumor account for further molecular and metabolic changes and for a persistent stimulation of angiogenesis